• Home
• Medizin ↘
  • ACM-Magazin
  • Einsatzgebiete
  • Nebenwirkungen
  • Studien & Fallberichte
  • Dokumente
• Wissenschaft ↘
  • Definitions
  • List of Clinical Studies
  • Database of Clinical Studies
  • Clinical Studies 2005-2009
  • Clinical Studies 2010-2014
• Recht und Politik ↘
  • Übersicht englisch
  • Austria/Österreich
  • Belgium
  • Canada
  • Chile
  • Croatia
  • Czech Republic
  • Denmark
  • Finland
  • France
  • Germany / Deutschland
  • Israel
  • Italy / Italia
  • Luxemburg/Luxembourg
  • New Zealand
  • Norway
  • Spain / España
  • Sweden
  • The Netherlands / Nederland
  • UK
  • United States of America
• Partner Weltweit ↘
  • Partnerorganisationen
• Archiv ↘
  • IACM-Informationen
  • ACM-Mitteilungen
• FAQ
• Sponsoren ↘
  • National
  • International
• Forum ↦
• Deutschland ↘
  • Recht ↘
    • Gesetze
    • Gerichtsurteile
  • Med. Möglichkeiten ↘
  • ACM
  • ACM-Mitteilungen
  • ACM-Mitteilungen abonnieren
  • Aktionen ↘
    • Kundgebung 2013
    • Petition 2014
    • Spendenaktion 2014
  • Selbsthilfenetzwerk
  • Dokumente
  • Kontakt
• Österreich ↘
• Schweiz
• Links ↘
  • International
  • Deutschland
• Über uns ↘
  • Vorstellung
  • Vorstand
  • Satzung
• Mitgliedschaft
• Spenden
• Impressum
• Datenschutzerklärung

Zeitschriften

• Rundbrief
  • IACM-Informationen
  • IACM abonnieren
  • ACM-Mitteilungen
  • ACM abonnieren
• Zeitschrift
  • CCR (aktuell)
  • Cannabinoids (ehemalig)
  • Therapeutics (ehemalig)
• Kongress & Webinare
  • Webinare & Jubiläums-Online-Sitzung (beides kostenlos)
  • Frühere Kongresse
  • ICRS
• Sprache
  • English
  • Deutsch
  • Français
  • Nederlands
  • Español
  • Português
  • Italiano

Sie sind hier: Startseite > Recht und Politik > Croatia

Croatia

 Last update: January 2019

The medical device for cannabis and cannabinoids was published on December 2018 by the European Monitoring Center for Drugs and Drug Addiction (EMCDDA). The full report may be accessed here .

Neither is it reimbursed by national health or social insurance companies. "In Croatia, medicinal products containing dronabinol, nabiximols and nabilone are available, with the former prescribed for symptoms of cancer and AIDS following the recommendation of a specialist physician.

As a result of media and public pressure in support of some patients, in October 2015 the national law has been changed to include medicines that contain THC, including preparations of plant material. Only a limited number of medical indications qualify for prescription, including multiple sclerosis, cancer, epilepsy and AIDS. Although it is possible for any general or family practitioner to write the prescription. The prescription should state the amount of THC in a single dose, the number of individual doses, drug form, dosage and method of use and, if applicable, so specify the type of herbal drugs and herbal preparation that should be used. The quantity prescribed may be sufficient for up to 30 days' use, up to a maximum allowable amount of 7.5 g of THC. Tilray products are imported to Croatia and are not reimbursed ".